Showing results (161-170 of 330) with videos related to

Sort By:
Pageof 33
JACC. Cardiooncology|April 5, 2021
The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil-Associated Coronary VasospasmAmna Zafar, Zsofia D Drobni, Ramya Mosarla, et al.
JACC. Cardiooncology|August 29, 2025
Diet and Prevention of Cardiovascular Disease and Cancer: JACC: CardioOncology State-of-the-Art ReviewSarah C Hull, Reed Mszar, Robert J Ostfeld, et al.
JACC. Cardiooncology|April 22, 2020
COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology CommunitiesBonnie Ky, Douglas L Mann
JACC. Cardiooncology|August 16, 2021
Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity: A Phase I TrialDarryl P Leong, Tammy Cosman, Muhammad M Alhussein, et al.
JACC. Cardiooncology|August 16, 2021
Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast CancerAriane V S Macedo, Ludhmila A Hajjar, Alexander R Lyon, et al.
JACC. Cardiooncology|August 16, 2021
Ischemia and Bleeding in Cancer Patients Undergoing Percutaneous Coronary InterventionYasushi Ueki, Benjamin Vögeli, Alexios Karagiannis, et al.
JACC. Cardiooncology|August 16, 2021
Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS)Kartik Anand, Joe Ensor, Barry Trachtenberg, et al.
JACC. Cardiooncology|August 16, 2021
Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics: What Is the Evidence?Janine A M Kamphuis, Marijke Linschoten, Maarten J Cramer, et al.
JACC. Cardiooncology|August 16, 2021
Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study DesignChiara Melloni, Susan F Slovin, Allan Blemings, et al.
JACC. Cardiooncology|August 16, 2021
The TICONC (Ticagrelor-Oncology) Study: Implications of P2Y12 Inhibition for Metastasis and Cancer-Associated ThrombosisJoy R Wright, Meera Chauhan, Chirag Shah, et al.
Pageof 33